Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Coagulation inhibitors

Citations 21-30 of 43 total displayed.

Past content (since Apr 2001):

Editorials
Direct Comparison of the A to Z and PROVE IT Trials: A Second Chance to Gain a First Impression
B. Greg Brown
Circulation 2006;113:1382-1384, doi:10.1161/CIRCULATIONAHA.106.612374 [Full text]  

Basic Science for Clinicians
Molecular Regulation of Platelet-Dependent Thrombosis
Jane E. Freedman
Circulation 2005;112:2725-2734, doi:10.1161/CIRCULATIONAHA.104.494468 [Abstract] [Full text]  

Surgery for Coronary Artery Disease
Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Jan van der Linden, Gabriella Lindvall, and Ulrik Sartipy
Circulation 2005;112:I-276-280I-, doi:10.1161/CIRCULATIONAHA.104.524611 [Abstract] [Full text]  

Editorials
Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Blockade: The Triad Revisited
W.H. Wilson Tang and A. Michael Lincoff
Circulation 2004;110:3618-3620, doi:10.1161/01.CIR.0000151355.07568.B4 [Full text]  

Review: Current Perspective
Bidirectional Relation Between Inflammation and Coagulation
Marcel Levi, Tom van der Poll, and Harry R. Büller
Circulation 2004;109:2698-2704, doi:10.1161/01.CIR.0000131660.51520.9A [Full text]  

Focused Perspectives
Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?
Jason H. Cole and William S. Weintraub
Circulation 2003;108:2831-2833, doi:10.1161/01.CIR.0000106681.88891.F2 [Full text]  

Correspondence
Clopidogrel in Acute Coronary Syndromes: Can the Cost Effectiveness Improve? Response
Enrique Sánchez-Delgado, Salim Yusuf, Shamir R. Mehta, Feng Zhao, Bernard J. Gersh, Patrick J. Commerford, Mel Blumenthal, Andrzej Budaj, Thomas Wittlinger, and Keith A.A. Fox
Circulation 2003;108:e56, doi:10.1161/01.CIR.0000086778.57755.6A [Full text]  

Cardiology Patient Pages
Antiplatelet Therapy
Robert A. Harrington, Patricia K. Hodgson, and Rhonda L. Larsen
Circulation 2003;108:e45-47e, doi:10.1161/01.CIR.0000083142.13956.D6 [Full text]  

Basic Science Reports
Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor
Jing Zhang, Orlando Piro, Lan Lu, and George J. Broze, Jr
Circulation 2003;108:623-627; published online before print as doi:10.1161/01.CIR.0000078642.45127.7B [Abstract] [Full text]  

Articles
Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor
Jing Zhang, Orlando Piro, Lan Lu, and George J. Broze, Jr
Circulation published June 30, 2003, doi:10.1161/01.CIR.0000078642.45127.7B [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5

* Subspecialty Collections Home

* Show  Coagulation inhibitors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors